FATE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.00%

Insider Buying (Last 12 Months): $668,579.52

Insider Selling (Last 12 Months): $25,352.29

Fate Therapeutics Insider Trading History Chart

Fate Therapeutics Share Price & Price History

^$0.68

▼ -0.09 (-11.69%)

As of 04/3/2025 05:00 PM ET

Days: 30 | 90 | 365

Fate Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/10/2025	Bahram Valamehr	CEO	Sell	8,705	$1.54	$13,405.70	349,364
1/10/2025	Jerome Charles Bressi	Insider	Sell	5,980	$1.55	$9,269.00	270,203
12/20/2024	Redmile Group, Llc	Director	Buy	397,964	$1.68	$668,579.52	12,884,277
8/6/2024	Yuan Xu	Director	Sell	633	$4.23	$2,677.59	8,669
1/29/2024	Edward J. Dulac, III	CFO	Sell	1,849	$5.00	$9,245.00	103,926
1/9/2024	Bahram Valamehr	Insider	Sell	11,271	$4.38	$49,366.98	158,069
1/9/2024	Cindy Tahl	General Counsel	Sell	10,874	$4.37	$47,519.38	142,361
1/9/2024	Edward J. Dulac, III	CFO	Sell	7,028	$4.37	$30,712.36	105,775
1/9/2024	J. Scott Wolchko	CEO	Sell	14,391	$4.37	$62,888.67	371,248
12/26/2023	Redmile Group, Llc	Director	Buy	44,630	$3.72	$166,023.60	13,180,388
8/18/2023	Edward J. Dulac, III	CFO	Sell	4,718	$2.80	$13,210.40	119,570
8/4/2023	Yuan Xu	Director	Sell	632	$3.71	$2,344.72	9,302
7/5/2023	Brian T Powl	Insider	Sell	3,854	$4.87	$18,768.98	41,146
7/5/2023	Edward J. Dulac, III	CFO	Sell	5,182	$4.83	$25,029.06	124,288
6/14/2023	Yuan Xu	Director	Sell	3,460	$5.58	$19,306.80	9,934
4/20/2023	Redmile Group, Llc	Director	Buy	20,000	$5.99	$119,800.00	12,879,119
4/18/2023	Yu-Waye Chu	Insider	Sell	2,532	$6.57	$16,635.24	140,676
4/14/2023	Redmile Group, Llc	Director	Buy	25,700	$6.00	$154,200.00	12,859,119
1/13/2023	John Mendlein	Director	Buy	36,631	$5.43	$198,906.33	282,770
1/11/2023	John Mendlein	Director	Buy	88,048	$5.67	$499,232.16	246,139
1/10/2023	Bahram Valamehr	Insider	Sell	10,917	$5.24	$57,205.08	168,917
1/10/2023	Cindy Tahl	General Counsel	Sell	11,553	$5.24	$60,537.72	177,598
1/10/2023	Edward J. Dulac, III	CFO	Sell	7,331	$5.24	$38,414.44	129,470
1/10/2023	J. Scott Wolchko	CEO	Sell	45,907	$5.24	$240,552.68	385,639
8/18/2022	Edward J. Dulac, III	CFO	Sell	5,135	$29.81	$153,074.35	136,801
7/21/2022	J. Scott Wolchko	CEO	Sell	30,000	$32.88	$986,400.00	431,546
7/7/2022	Bahram Valamehr	Insider	Sell	17,158	$30.23	$518,686.34	179,834
7/5/2022	Mark Plavsic	Insider	Sell	3,719	$24.61	$91,524.59	127,123
6/7/2022	Shefali Agarwal	Director	Sell	841	$21.89	$18,409.49	1,840
6/3/2022	John Mendlein	Director	Sell	1,364	$22.79	$31,085.56	158,091
4/21/2022	J. Scott Wolchko	CEO	Sell	30,000	$35.00	$1,050,000.00	431,546
4/19/2022	Yu-Waye Chu	Insider	Sell	4,062	$35.37	$143,672.94	151,033
4/1/2022	Cindy Tahl	General Counsel	Sell	25,000	$38.85	$971,250.00	189,151

See Full Table

SEC Filings (Institutional Ownership Changes) for Fate Therapeutics (NASDAQ:FATE)

97.54% of Fate Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Fate Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/19/2025	Public Employees Retirement System of Ohio	88,766	$0.15M	0.0%	-34.2%	0.078%
2/17/2025	Woodline Partners LP	1,422,785	$2.35M	0.0%	-53.6%	1.249%
2/17/2025	Vestal Point Capital LP	2,465,000	$4.07M	0.2%	+46.3%	2.164%
2/17/2025	Squarepoint Ops LLC	34,295	$57K	0.0%	+154.2%	0.030%
2/17/2025	Two Sigma Investments LP	297,106	$0.49M	0.0%	-35.4%	0.261%
2/17/2025	Two Sigma Advisers LP	828,100	$1.37M	0.0%	-10.7%	0.727%
2/17/2025	Tang Capital Management LLC	1,855,954	$3.06M	0.2%	+165.1%	1.630%
2/17/2025	Sphera Funds Management LTD.	397,177	$0.66M	0.1%	N/A	0.349%
2/17/2025	Redmile Group LLC	12,872,946	$21.24M	1.5%	-2.2%	11.303%
2/17/2025	Point72 Asia Singapore Pte. Ltd.	33,094	$55K	0.0%	N/A	0.029%
2/17/2025	ProShare Advisors LLC	33,645	$56K	0.0%	+77.9%	0.030%
2/17/2025	Millennium Management LLC	413,192	$0.68M	0.0%	+28.9%	0.363%
2/17/2025	Integral Health Asset Management LLC	600,000	$0.99M	0.1%	-38.5%	0.527%
2/17/2025	Graham Capital Management L.P.	22,342	$37K	0.0%	N/A	0.020%
2/17/2025	D. E. Shaw & Co. Inc.	1,536,633	$2.54M	0.0%	-54.5%	1.349%
2/17/2025	Brevan Howard Capital Management LP	24,636	$41K	0.0%	N/A	0.022%
2/17/2025	Baker BROS. Advisors LP	3,258,402	$5.38M	0.1%	+8.7%	2.861%
2/17/2025	Bank of America Corp DE	304,129	$0.50M	0.0%	-64.4%	0.267%
2/17/2025	BNP Paribas Financial Markets	287,711	$0.48M	0.0%	+65.2%	0.253%
2/17/2025	Ameriprise Financial Inc.	177,161	$0.29M	0.0%	-29.1%	0.156%
2/14/2025	Jane Street Group LLC	30,780	$51K	0.0%	-79.2%	0.027%
2/14/2025	Northern Trust Corp	805,518	$1.33M	0.0%	-1.2%	0.707%
2/14/2025	Susquehanna Fundamental Investments LLC	118,186	$0.20M	0.0%	N/A	0.104%
2/14/2025	Price T Rowe Associates Inc. MD	38,049	$63K	0.0%	-41.7%	0.033%
2/14/2025	Dark Forest Capital Management LP	61,220	$0.10M	0.0%	+128.0%	0.054%
2/14/2025	Hsbc Holdings PLC	109,422	$0.18M	0.0%	+22.0%	0.096%
2/14/2025	MetLife Investment Management LLC	16,641	$27K	0.0%	-61.0%	0.015%
2/14/2025	Dimensional Fund Advisors LP	2,898,377	$4.78M	0.0%	+10.7%	2.545%
2/13/2025	CANADA LIFE ASSURANCE Co	21,267	$35K	0.0%	-53.4%	0.019%
2/13/2025	Marshall Wace LLP	512,641	$0.85M	0.0%	N/A	0.450%
2/13/2025	Walleye Capital LLC	1,083,092	$1.79M	0.0%	+1,502.0%	0.951%
2/13/2025	XTX Topco Ltd	249,800	$0.41M	0.0%	N/A	0.219%
2/13/2025	Renaissance Technologies LLC	378,619	$0.63M	0.0%	+4.4%	0.332%
2/13/2025	Cerity Partners LLC	823,134	$1.36M	0.0%	+4,953.6%	0.723%
2/13/2025	Federated Hermes Inc.	543,021	$0.90M	0.0%	-1.8%	0.477%
2/13/2025	Aristides Capital LLC	100,555	$0.17M	0.0%	N/A	0.088%
2/13/2025	Russell Investments Group Ltd.	89,823	$0.15M	0.0%	+42.9%	0.079%
2/13/2025	Wells Fargo & Company MN	92,395	$0.15M	0.0%	+56.3%	0.081%
2/12/2025	Geode Capital Management LLC	2,226,967	$3.68M	0.0%	-1.4%	1.955%
2/12/2025	Franklin Resources Inc.	165,353	$0.27M	0.0%	+9.6%	0.145%
2/12/2025	BIT Capital GmbH	247,564	$0.41M	0.0%	N/A	0.217%
2/12/2025	JPMorgan Chase & Co.	1,669,562	$2.76M	0.0%	-9.1%	1.466%
2/11/2025	Prudential Financial Inc.	321,401	$0.53M	0.0%	-9.9%	0.282%
2/11/2025	Vanguard Group Inc.	10,333,033	$17.05M	0.0%	-0.7%	9.073%
2/11/2025	LPL Financial LLC	73,120	$0.12M	0.0%	N/A	0.064%
2/11/2025	American Century Companies Inc.	197,704	$0.33M	0.0%	+6.6%	0.174%
2/11/2025	Privium Fund Management B.V.	87,000	$0.14M	0.0%	+74.0%	0.076%
2/11/2025	Intech Investment Management LLC	39,443	$65K	0.0%	+27.5%	0.035%
2/10/2025	Thrivent Financial for Lutherans	89,322	$0.15M	0.0%	-28.8%	0.078%
2/10/2025	Monaco Asset Management SAM	327,671	$0.54M	0.1%	+138.0%	0.288%
2/7/2025	E Fund Management Co. Ltd.	339,994	$0.56M	0.0%	-3.9%	0.299%
2/4/2025	Y Intercept Hong Kong Ltd	35,360	$58K	0.0%	N/A	0.031%
2/4/2025	FPC Investment Advisory Inc.	26,456	$44K	0.0%	N/A	0.023%
1/28/2025	Leo Wealth LLC	70,439	$0.12M	0.0%	+574.8%	0.062%
1/24/2025	China Universal Asset Management Co. Ltd.	24,150	$40K	0.0%	N/A	0.021%
1/23/2025	Institute for Wealth Management LLC.	66,886	$0.11M	0.0%	N/A	0.059%
1/17/2025	SG Americas Securities LLC	44,874	$74K	0.0%	+30.6%	0.039%
1/14/2025	Assenagon Asset Management S.A.	372,507	$0.62M	0.0%	-84.7%	0.327%
12/26/2024	JPMorgan Chase & Co.	1,837,304	$6.43M	0.0%	+18.2%	1.613%
11/27/2024	Franklin Resources Inc.	150,821	$0.53M	0.0%	-34.4%	0.132%
11/19/2024	Barclays PLC	424,277	$1.49M	0.0%	+245.3%	0.373%
11/16/2024	Geode Capital Management LLC	2,258,246	$7.91M	0.0%	+0.5%	1.983%
11/15/2024	Barclays PLC	424,277	$1.49M	0.0%	+245.3%	0.373%
11/15/2024	Jane Street Group LLC	147,872	$0.52M	0.0%	-32.1%	0.130%
11/15/2024	State Street Corp	5,252,974	$18.39M	0.0%	-1.6%	4.613%
11/15/2024	Stifel Financial Corp	24,096	$84K	0.0%	-41.9%	0.021%
11/15/2024	Jacobs Levy Equity Management Inc.	1,587,900	$5.56M	0.0%	-6.3%	1.394%
11/14/2024	Vestal Point Capital LP	1,685,000	$5.90M	0.4%	-15.8%	1.480%
11/14/2024	Walleye Capital LLC	67,609	$0.24M	0.0%	+263.5%	0.059%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	142,131	$0.50M	0.0%	-24.6%	0.125%
11/14/2024	MetLife Investment Management LLC	42,652	$0.15M	0.0%	-28.9%	0.037%
11/13/2024	BNP Paribas Financial Markets	174,148	$0.61M	0.0%	+1,307.6%	0.153%
11/13/2024	FMR LLC	227,981	$0.80M	0.0%	+25.9%	0.200%
11/12/2024	Charles Schwab Investment Management Inc.	763,808	$2.67M	0.0%	-13.1%	0.671%
11/9/2024	Intech Investment Management LLC	30,946	$0.11M	0.0%	N/A	0.027%
11/7/2024	Thrivent Financial for Lutherans	125,370	$0.44M	0.0%	+24.7%	0.110%
11/6/2024	Cornercap Investment Counsel Inc.	20,683	$72K	0.0%	-52.4%	0.018%
11/5/2024	Victory Capital Management Inc.	12,078	$42K	0.0%	-88.4%	0.011%
11/2/2024	Privium Fund Management B.V.	50,000	$0.18M	0.0%	N/A	0.044%
10/23/2024	Assenagon Asset Management S.A.	2,434,198	$8.52M	0.0%	-5.5%	2.138%
10/21/2024	Castleview Partners LLC	20,826	$73K	0.0%	N/A	0.018%
10/10/2024	Exchange Traded Concepts LLC	42,289	$0.15M	0.0%	+40.7%	0.037%
8/16/2024	Perceptive Advisors LLC	345,575	$1.13M	0.0%	N/A	0.304%
8/16/2024	Doheny Asset Management CA	7,670	$0.26M	0.1%	N/A	0.007%
8/16/2024	Algert Global LLC	65,611	$0.22M	0.0%	+318.4%	0.058%
8/15/2024	Susquehanna Fundamental Investments LLC	262,414	$0.86M	0.0%	+73.6%	0.231%
8/15/2024	The Manufacturers Life Insurance Company	39,715	$0.13M	0.0%	-33.6%	0.035%
8/15/2024	Dark Forest Capital Management LP	19,065	$63K	0.0%	N/A	0.017%
8/15/2024	Deerfield Management Company L.P. Series C	3,555,871	$11.66M	0.2%	+62.3%	3.124%
8/15/2024	AQR Capital Management LLC	16,460	$54K	0.0%	-25.5%	0.014%
8/15/2024	Caxton Associates LP	172,863	$0.57M	0.0%	-40.4%	0.152%
8/14/2024	Squarepoint Ops LLC	128,759	$0.42M	0.0%	N/A	0.113%
8/14/2024	Marshall Wace LLP	330,082	$1.08M	0.0%	-4.4%	0.290%
8/14/2024	Integral Health Asset Management LLC	850,000	$2.79M	0.3%	+325.0%	0.747%
8/14/2024	DRW Securities LLC	21,550	$71K	0.0%	N/A	0.019%
8/14/2024	ProShare Advisors LLC	11,351	$37K	0.0%	-25.5%	0.010%
8/14/2024	Profund Advisors LLC	46,528	$0.15M	0.0%	-58.6%	0.041%
8/12/2024	XTX Topco Ltd	33,898	$0.11M	0.0%	+95.0%	0.030%
8/12/2024	Hsbc Holdings PLC	88,514	$0.28M	0.0%	+34.3%	0.078%
8/12/2024	E Fund Management Co. Ltd.	355,225	$1.17M	0.1%	+930.2%	0.312%

Data available starting January 2016

See Full Table

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma, and FT522, to treat lymphoma and autoimmune disorders. Its CAR T-cell programs include FT819 to treat hematologic malignancies and solid tumors, and FT825 to treat solid tumors. The company has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of cancer. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Today's Range

Now: $0.68

$0.68

$0.74

50 Day Range

MA: $1.13

$0.68

$1.71

52 Week Range

Now: $0.68

$0.68

$7.35

Volume

2,422,838 shs

Average Volume

2,296,285 shs

Market Capitalization

$77.93 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.26

Who are the company insiders with the largest holdings of Fate Therapeutics?: Fate Therapeutics' top insider investors include:
Redmile Group, Llc (Director)
J Scott Wolchko (CEO)
Bahram Valamehr (CEO)
Jerome Charles Bressi (Insider)
Bahram Valamehr (Insider)
Cindy Tahl (General Counsel)
Yu-Waye Chu (Insider)
Edward J Dulac III (CFO)
Brian T Powl (Insider)
Yuan Xu (Director)
Learn More about top insider investors at Fate Therapeutics.

FATE Insider Trading

Fate Therapeutics Insider Trading History Chart

Fate Therapeutics Share Price & Price History

Fate Therapeutics Insider Trading History

SEC Filings (Institutional Ownership Changes) for Fate Therapeutics (NASDAQ:FATE)

Institutional Buying and Selling by Quarter

Fate Therapeutics Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Fate Therapeutics?